journal article·2024-01-12

Fluorinated Peptide Nanoscale Hydrogel Accelerates Wound Healing via pH and Oxygen Microenvironment Regulation

Leixia Mei, Haihong Yang, Weimiao Dong, Min Liu, Jun Han

ACS Applied Nano Materials· Volume 7· Issue 1
Publisher page

Abstract

The abnormal levels of pH and oxygen (O 2 ) in the wound microenvironment impeded wound healing, and their regulation remains a challenge. Thus, a wound dressing with pH and O 2 -regulating capacity is urgently desired. Here, we designed and prepared a fluorinated peptide hydrogel wound dressing to regulate the pH and O 2 microenvironment of the wound site. Fluorinated peptides with the (naphthalene-2-ly)-Gly- 5f Phe- 5f Phe-Tyr-Arg-Gly-Asp sequence (F 5 –Pep) could self-assemble to a nanofiber network in a weak acidic buffer (pH = 6.0), which is similar to the pH of human skin. The F 5 –Pep hydrogel can maintain pH levels at 6.0–7.3 for 24 h and continuously release O 2 for 4 h. The blood coagulation and hemostasis assay showed that the F 5 –Pep hydrogel significantly accelerated blood clotting speed in vitro and rapidly controlled hemorrhage in a mouse liver hemorrhage model. In vitro cell migration assays and in vivo animal experiments confirmed that the F 5 –Pep hydrogel can promote cell migration and wound healing. In summary, this work might provide an effective treatment strategy for wounds and develop advanced wound-healing materials.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Antimicrobial Peptides and Activities · Wound Healing and Treatments · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Biopharmaceutical Research, Liaocheng University, Liaocheng 252059, China

School of Chemistry and Chemical Engineering, Liaocheng University, Liaocheng 252059, China

Liaocheng High-Tech Biotechnology Co., Ltd., Liaocheng 252000, China

Funding

Liaocheng University · National Natural Science Foundation of China

References (66)

Show source-provided references
1. 10.34133/2022/985074310.34133/2022/9850743 ↗
2. 10.18063/ijb.68910.18063/ijb.689 ↗
3. 10.1089/wound.2020.121010.1089/wound.2020.1210 ↗
4. 10.1016/j.addr.2023.11475310.1016/j.addr.2023.114753 ↗
5. 10.1002/adhm.20210047710.1002/adhm.202100477 ↗
6. 10.1016/j.addr.2018.03.01210.1016/j.addr.2018.03.012 ↗
7. 10.1097/SCS.0b013e31827104fb10.1097/SCS.0b013e31827104fb ↗
8. 10.1038/s41598-020-70079-x10.1038/s41598-020-70079-x ↗
9. 10.3390/polym1504098610.3390/polym15040986 ↗
10. 10.1002/adfm.20190549310.1002/adfm.201905493 ↗
11. 10.1053/j.semvascsurg.2016.01.00310.1053/j.semvascsurg.2016.01.003 ↗
12. 10.3390/molecules2312338310.3390/molecules23123383 ↗
13. 10.1002/adfm.20210259910.1002/adfm.202102599 ↗
14. 10.3390/s1905099110.3390/s19050991 ↗
15. 10.1021/acsami.2c1565910.1021/acsami.2c15659 ↗
16. 10.1111/wrr.1212510.1111/wrr.12125 ↗
17. 10.1016/j.mtbio.2023.10057410.1016/j.mtbio.2023.100574 ↗
18. 10.1159/00048952210.1159/000489522 ↗
19. 10.1002/adfm.20221511610.1002/adfm.202215116 ↗
20. 10.1002/advs.20220125410.1002/advs.202201254 ↗
21. 10.1089/wound.2011.031910.1089/wound.2011.0319 ↗
22. 10.3390/ijerph1722869310.3390/ijerph17228693 ↗
23. 10.1111/jcmm.1226510.1111/jcmm.12265 ↗
24. 10.1007/s11481-014-9531-710.1007/s11481-014-9531-7 ↗
25. 10.1016/j.cej.2023.14150710.1016/j.cej.2023.141507 ↗
26. 10.1021/acsami.1c0499610.1021/acsami.1c04996 ↗
27. 10.1111/j.1524-475X.2008.00436.x10.1111/j.1524-475X.2008.00436.x ↗
28. 10.1002/adtp.20200010710.1002/adtp.202000107 ↗
29. 10.1007/s00268-003-7400-210.1007/s00268-003-7400-2 ↗
30. 10.1111/apm.1316410.1111/apm.13164 ↗
31. 10.1021/acsami.0c0573210.1021/acsami.0c05732 ↗
32. 10.1038/s41378-020-0141-710.1038/s41378-020-0141-7 ↗
33. 10.1007/s00424-020-02482-210.1007/s00424-020-02482-2 ↗
34. 10.1186/s13568-023-01533-y10.1186/s13568-023-01533-y ↗
35. 10.1097/CM9.000000000000207610.1097/CM9.0000000000002076 ↗
36. 10.1089/wound.2020.123210.1089/wound.2020.1232 ↗
37. 10.1007/s40820-021-00751-y10.1007/s40820-021-00751-y ↗
38. 10.3390/nano1205078410.3390/nano12050784 ↗
39. 10.1002/advs.20210416510.1002/advs.202104165 ↗
40. 10.3390/ma1517587110.3390/ma15175871 ↗
41. 10.3390/pharmaceutics1501006810.3390/pharmaceutics15010068 ↗
42. 10.1002/cbic.20220049910.1002/cbic.202200499 ↗
43. 10.1039/D0SM01136C10.1039/D0SM01136C ↗
44. 10.1039/c2jm31290e10.1039/c2jm31290e ↗
45. 10.2147/IJN.S1527910.2147/IJN.S15279 ↗
46. 10.1002/psc.352410.1002/psc.3524 ↗
47. 10.1016/j.ijbiomac.2022.12.08510.1016/j.ijbiomac.2022.12.085 ↗
48. 10.1016/j.colsurfb.2022.11306310.1016/j.colsurfb.2022.113063 ↗
49. 10.1002/adhm.20220330110.1002/adhm.202203301 ↗
50. 10.1016/j.bioactmat.2021.06.01410.1016/j.bioactmat.2021.06.014 ↗
51. 10.1002/smll.20190004610.1002/smll.201900046 ↗
52. 10.1021/acsabm.2c0013810.1021/acsabm.2c00138 ↗
53. 10.1016/j.jcis.2022.05.01310.1016/j.jcis.2022.05.013 ↗
54. 10.3892/mmr.2014.192110.3892/mmr.2014.1921 ↗
55. 10.1016/j.actbio.2021.08.00810.1016/j.actbio.2021.08.008 ↗
56. 10.1021/acsbiomaterials.0c0126410.1021/acsbiomaterials.0c01264 ↗
57. 10.1016/S1381-5148(99)00031-010.1016/S1381-5148(99)00031-0 ↗
58. 10.1016/j.actbio.2012.10.03410.1016/j.actbio.2012.10.034 ↗
59. 10.1039/C5TB02635K10.1039/C5TB02635K ↗
60. 10.1016/j.bioadv.2022.21303410.1016/j.bioadv.2022.213034 ↗
61. 10.1039/D3RA00476G10.1039/D3RA00476G ↗
62. 10.1016/j.biomaterials.2021.12133010.1016/j.biomaterials.2021.121330 ↗
63. 10.1016/j.ijbiomac.2020.12.22110.1016/j.ijbiomac.2020.12.221 ↗
64. 10.1021/acs.biomac.9b0136810.1021/acs.biomac.9b01368 ↗
65. 10.1039/b714750c10.1039/b714750c ↗
66. 10.1021/acs.jpcb.9b0299910.1021/acs.jpcb.9b02999 ↗